Carol Mathew
@heme-enthusiast.bsky.social
Classical hematologist; Medical Educator
Reposted by Carol Mathew
RENOVE trial
Reduced dose DOAC was not non inferior to full dose (2.2% vs 1.8%, P=0.23) but lower risk of clinically relevant bleeding (9.9 vs 15.2%) for extended duration anticoagulation for the secondary prevention of recurrent VTE
Risk benefit seems to favor reduced dosing for most patients
Reduced dose DOAC was not non inferior to full dose (2.2% vs 1.8%, P=0.23) but lower risk of clinically relevant bleeding (9.9 vs 15.2%) for extended duration anticoagulation for the secondary prevention of recurrent VTE
Risk benefit seems to favor reduced dosing for most patients
December 10, 2024 at 4:18 PM
RENOVE trial
Reduced dose DOAC was not non inferior to full dose (2.2% vs 1.8%, P=0.23) but lower risk of clinically relevant bleeding (9.9 vs 15.2%) for extended duration anticoagulation for the secondary prevention of recurrent VTE
Risk benefit seems to favor reduced dosing for most patients
Reduced dose DOAC was not non inferior to full dose (2.2% vs 1.8%, P=0.23) but lower risk of clinically relevant bleeding (9.9 vs 15.2%) for extended duration anticoagulation for the secondary prevention of recurrent VTE
Risk benefit seems to favor reduced dosing for most patients
Reposted by Carol Mathew
Are you feeling revitalized? 🎇
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
December 10, 2024 at 2:18 PM
Are you feeling revitalized? 🎇
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
#ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned.
Here's to a fantastic final day in San Diego!☀️ #HemeSky #Hematology
Reposted by Carol Mathew
Treating Fairly launched at the #ASH24 Quality Symposium! 🚀This pilot program is modeled after the highly successful Choosing Wisely initiative.
We invite ASH members to share ideas and topics for the Treating Fairly initiative: bit.ly/4gnfYPp
#HemeSky #Hematology
We invite ASH members to share ideas and topics for the Treating Fairly initiative: bit.ly/4gnfYPp
#HemeSky #Hematology
December 8, 2024 at 6:38 PM
Treating Fairly launched at the #ASH24 Quality Symposium! 🚀This pilot program is modeled after the highly successful Choosing Wisely initiative.
We invite ASH members to share ideas and topics for the Treating Fairly initiative: bit.ly/4gnfYPp
#HemeSky #Hematology
We invite ASH members to share ideas and topics for the Treating Fairly initiative: bit.ly/4gnfYPp
#HemeSky #Hematology
Reposted by Carol Mathew
Reposted by Carol Mathew
"The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom."
- Isaac Asimov
- Isaac Asimov
December 9, 2024 at 3:21 PM
"The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom."
- Isaac Asimov
- Isaac Asimov
Reposted by Carol Mathew
“In the long run, there are no secrets in science. The universe will not cooperate in a cover-up.”
— Arthur C. Clarke
— Arthur C. Clarke
December 10, 2024 at 2:43 AM
“In the long run, there are no secrets in science. The universe will not cooperate in a cover-up.”
— Arthur C. Clarke
— Arthur C. Clarke